Pneumonia and Renal Replacement Therapy Are Risk Factors for Ceftazidime-Avibactam Treatment Failures and Resistance among Patients with Carbapenem-Resistant Enterobacteriaceae Infections [Clinical Therapeutics] - Shields, R. K., Nguyen, M. H., Chen, L., Press, E. G., Kreiswirth, B. N., Clancy, C. J. (The American Society for Microbiology (ASM), 2018)
6245104